(Q36918196)

17 August 2017

1 reference

title

Cognitive dysfunction associated with metabolic syndrome (English)

1 reference

17 August 2017

1 reference

cognitive dysfunction

1 reference

Taylor VH

1

1 reference

17 August 2017

MacQueen GM

series ordinal

2

1 reference

17 August 2017

publication date

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

409-418

1 reference

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Fall and injury prevention in residential care--effects in residents with higher and lower levels of cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Interactive effect of obesity indexes on cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Novel actions of leptin in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

The metabolic syndrome, inflammation, and risk of cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Inflammatory markers and cognition in well-functioning African-American and white elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Inflammation markers in relation to cognition in a healthy aging population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

The effect of weight-loss dieting on cognitive performance and psychological well-being in overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Breakfast, blood glucose and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Neuropsychological consequences of extreme weight loss and dietary restriction in patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

The effects of food deprivation and incentive motivation on blood glucose levels and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Obesity is an environmental issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Social and biological determinants of cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

High-fat diets, insulin resistance and declining cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Studies of the effects of high fat diets on cognitive function in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Essential fatty acids and the brain: from infancy to aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Diabetes mellitus in midlife and the risk of dementia three decades later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Type 2 diabetes mellitus, cognitive impairment and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Obesity, diabetes and cognitive deficit: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Type 2 diabetes and cognitive function in community-dwelling elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Glucose tolerance and cognitive impairment in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

The effects of type 1 diabetes on cognitive performance: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Relationship between hyperglycemia and cognitive function in older NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Altered glycemia and brain-update and potential relevance to the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Neuropsychological Profiles of Children With Type 1 Diabetes 6 Years After Disease Onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Intellectual deficits associated with early onset of insulin-dependent diabetes mellitus in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Urinary cortisol excretion as a predictor of incident cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Links between cognitive impairment in insulin resistance: an explanatory model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Insulin-like growth factor 1 regulates developing brain glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cognition and synaptic plasticity in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Direct insulin signaling of neurons reverses diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Pathological changes in the central and peripheral nervous system of young long-term diabetics : I. Diabetic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Effect of long-term glycemic control on cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Hypertension affects neurobehavioral functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Progress in cardiovascular diseases: cognitive function in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Hypertension and cerebral white matter lesions in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Reduction of functional neuronal connectivity in long-term treated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Regional cerebral blood flow in patients with leuko-araiosis and atherosclerotic carotid artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Brain atrophy in hypertension. A volumetric magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

White matter lesions and cognitive impairment as silent cerebral disease in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Amyloid and lipids in the pathology of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Association between high-density lipoprotein and cognitive impairment in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Serum lipoprotein levels, statin use, and cognitive function in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cardiovascular disease risk factors and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00401.X

10.1111/J.1467-789X.2007.00401.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference